Anemia in Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Anemia in Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Do Iron And Vitamin B12 Injections Given Together, Improve Hemoglobin In Patients On Hemodialysis? [Phase 4]
A Phase 4 trial assessing whether iron and vitamin B12 injections given together improve hemoglobin in patients on hemodialysis.
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients [Phase 3]
Phase 3 randomized trial comparing subcutaneous EPO HEXAL to ERYPO in predialysis chronic renal insufficiency patients; study terminated wit…
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: Anaemia Correction in Haemodialyzed Patients - Comparative Analysis of Two Erythropoietin Stimulating Agents Schedules [Phase 4]
Phase 4 trial assessing bio-equivalency of two erythropoietin stimulating agent schedules in haemodialysis patients; study withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: A Non-interventional Study of Diafer in Subjects With CKD on Haemodialysis for Treatment of Iron Deficiency
A completed non-interventional study evaluating Diafer (ferric carboxymaltose) for iron deficiency in adults with chronic kidney disease on …
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: A Study of Monthly Subcutaneous Continuous Erythropoietin Receptor Activator (CERA) in Predialysis Participants With Chronic Renal Anemia [Phase 3]
Phase 3 trial evaluating monthly subcutaneous continuous erythropoietin receptor activator (CERA) for anemia in predialysis chronic kidney d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD [EARLY_Phase 1]
FerruMax's exploratory Phase 1 trial of FMX-8 for anemia in chronic kidney disease has been terminated. The update notes the study status as…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China [Phase 2]
Phase 2 study of FG-4592 (roxadustat) for anemia in end-stage renal disease patients on maintenance hemodialysis in China has completed.